| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/14/2006 | EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders |
| 06/14/2006 | EP1669070A2 2-imino-thiazolidine and -oxazolidine derivatives for use as antiinflammatory agents |
| 06/14/2006 | EP1668036A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 06/14/2006 | EP1668024A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 06/14/2006 | EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors |
| 06/14/2006 | EP1667707A1 Methods of stimulating innate immunity using cationic peptides |
| 06/14/2006 | EP1667697A2 Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium. |
| 06/14/2006 | EP1667657A1 Topical aerosol foams |
| 06/14/2006 | EP1567507B1 1,2,3- triazole amide derivatives as cytokine inhibitors |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1471931A4 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1377577B1 Pyrrole derivates for treating cytokine mediated diseases |
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | EP1289475B1 Water-thin emulsions with low emulsifier levels |
| 06/14/2006 | EP1285661B1 Use of an antioxidant comprising an extract of mozuku |
| 06/14/2006 | EP1278825B1 Methods of producing membrane vesicles |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1255558B1 Anti-april antibodies and hybridoma cells |
| 06/14/2006 | EP1210100B1 Method of treating traumatic brain using non-steroidal anti-inflammatory drugs |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | EP1071439B1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
| 06/14/2006 | DE102004059357A1 New antibody (which specifically recognizes human thiamine 1) useful for blocking the binding of human Thy-1 at its ligand or for blocking the interaction of tumor cells or immune cells with endothelial cells |
| 06/14/2006 | CN1788007A Crystal of benzimidazole derivative and process for producing the same |
| 06/14/2006 | CN1788001A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/14/2006 | CN1787993A S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt |
| 06/14/2006 | CN1787832A Method of treating inflammtory disease associated with bone destruction |
| 06/14/2006 | CN1787825A External patch containing estrogen and/or progestogen |
| 06/14/2006 | CN1785995A 2,5-disubstituted-1,3-dioxygen cycle compound, their synthesis and application as PKC inhibiter |
| 06/14/2006 | CN1785991A Anti inflammatory detoxication luteolin kind new medicine and its preparation method |
| 06/14/2006 | CN1785410A Preparation method of ready prepared chinese medicinal granules for treathing pains |
| 06/14/2006 | CN1785371A Chinese medicinal preparation for abating child fever and its preparation method |
| 06/14/2006 | CN1785354A New compound Chinese medicinal preparation for anti rheumatism and its preparation technology |
| 06/14/2006 | CN1785349A Medicinal wine for treating knocks and falls |
| 06/14/2006 | CN1785347A Quality control method of Chinese medicinal preparation for treating child hyperpyrexia |
| 06/14/2006 | CN1785297A Panax pseudo-ginseng wsll. var. network quickening dampness damage pain relieving plaster |
| 06/14/2006 | CN1785296A Medicine having phlegm expelling, cough settling, panting calming, heat resolving funetions |
| 06/14/2006 | CN1785290A Lumbar invigorating kidney fortifying fast dispersion solid medicine and its preparation method |
| 06/14/2006 | CN1785282A Caragana network vessel quickening dampness damage pain relieving plaster |
| 06/14/2006 | CN1785276A Medicine for treating atrophic arthritis |
| 06/14/2006 | CN1785272A Medicinal composition and its preparation method |
| 06/14/2006 | CN1785268A Quality control method of sinew soothing and pain relieving preparation |
| 06/14/2006 | CN1785238A Application of pulvis pro clavus extractive total flavone in preparing anti-inflammatory agent |
| 06/14/2006 | CN1785237A Duyiwei dripping pill prepn. and its preparing method |
| 06/14/2006 | CN1785225A Medicated wine for dispelling gall |
| 06/14/2006 | CN1785221A Powder injection contg. radix bupleuri and its prepn. method |
| 06/14/2006 | CN1785177A Medicinal composition contg. isoandrographolide and its medicinal use |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/14/2006 | CN1259098C Exterior-applied Chinese herbal medicine preparation for traumatic infection and inflammation-relieving acesodyne and its preparation method |
| 06/14/2006 | CN1259086C Medicine for treating arthromyodynia |
| 06/14/2006 | CN1259072C Medicine for treating rheumatic or rheumatoid arthritis and its preparation method |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/14/2006 | CN1259046C Soyisoflavone soft capsule and its preparation technology |
| 06/14/2006 | CN1259038C Radix bupleuri soft capsule pharmaceutics and preparation process thereof |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060834 Using a 2-aminoquinoline compound |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060821 Osteoclast differentiation inhibitors |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant |
| 06/13/2006 | US7060730 Rapidly absorbed liquid compositions |
| 06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060707 Isoquinoline derivatives |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060686 treating, preventing, or inhibiting disorders associated with inflammation, cell-proliferation, and pain by administering a pseudopterosin, a seco-pseudopterosin, a diterpene aglycone, or a tricyclic diterpene |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060672 Cyclosporin analog formulations |
| 06/13/2006 | US7060504 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060285 Dispersions for the formulation of slightly or poorly soluble agents |
| 06/13/2006 | US7060262 Administering granulocyte colony stimulating factor; Crohn's disease |
| 06/13/2006 | US7060259 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 06/13/2006 | US7060254 Aerosol; heating thin film on solid support; vaporization with air flow |
| 06/13/2006 | CA2366623C Resorcinol composition |
| 06/13/2006 | CA2302601C Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059785A1 Development of bioactive agent using dendritic cell differentiation-inducing factor |
| 06/08/2006 | WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 06/08/2006 | WO2006059714A1 Composition for prevention and/or treatment of bone diseases, physiologically functional or health foods containing the composition, and medicinal preparations containing the composition as the active ingredient |
| 06/08/2006 | WO2006059328A1 Treatment of inflammation |
| 06/08/2006 | WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 06/08/2006 | WO2006011024A9 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/08/2006 | WO2005116067A3 Msh-agonist tripeptide conjugates |
| 06/08/2006 | WO2005099671A3 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 06/08/2006 | US20060122402 Manufacturing process for no-donating compounds such as no-donating diclofenac |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122275 Agentfor reducing side effects of diclofenac |